195 related articles for article (PubMed ID: 19360331)
1. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Nakamura J; Aoyagi S; Nanchi I; Nakatsuka S; Hirata E; Shibata S; Fukuda M; Yamamoto Y; Fukuda I; Tatsumi N; Ueda T; Fujiki F; Nomura M; Nishida S; Shirakata T; Hosen N; Tsuboi A; Oka Y; Nezu R; Mori M; Doki Y; Aozasa K; Sugiyama H; Oji Y
Int J Oncol; 2009 May; 34(5):1181-9. PubMed ID: 19360331
[TBL] [Abstract][Full Text] [Related]
2. Activation of the ribosomal protein L13 gene in human gastrointestinal cancer.
Kobayashi T; Sasaki Y; Oshima Y; Yamamoto H; Mita H; Suzuki H; Toyota M; Tokino T; Itoh F; Imai K; Shinomura Y
Int J Mol Med; 2006 Jul; 18(1):161-70. PubMed ID: 16786168
[TBL] [Abstract][Full Text] [Related]
3. Few point mutations in elongation factor-1gamma gene in gastrointestinal carcinoma.
Frazier ML; Inamdar N; Alvula S; Wu E; Kim YH
Mol Carcinog; 1998 May; 22(1):9-15. PubMed ID: 9609096
[TBL] [Abstract][Full Text] [Related]
4. Akt-induced promotion of cell-cycle progression at G2/M phase involves upregulation of NF-Y binding activity in PC12 cells.
Lee SR; Park JH; Park EK; Chung CH; Kang SS; Bang OS
J Cell Physiol; 2005 Nov; 205(2):270-7. PubMed ID: 15887249
[TBL] [Abstract][Full Text] [Related]
5. ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features.
Osada H; Tatematsu Y; Yatabe Y; Horio Y; Takahashi T
Cancer Res; 2005 Dec; 65(23):10680-5. PubMed ID: 16322211
[TBL] [Abstract][Full Text] [Related]
6. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer.
Shi Y; Ding X; He ZH; Zhou KC; Wang Q; Wang YZ
Gut; 2009 Nov; 58(11):1443-50. PubMed ID: 19651628
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence.
Byun HO; Han NK; Lee HJ; Kim KB; Ko YG; Yoon G; Lee YS; Hong SI; Lee JS
Cancer Res; 2009 Jun; 69(11):4638-47. PubMed ID: 19487283
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
[TBL] [Abstract][Full Text] [Related]
11. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells.
Boutros R; Byrne JA
Exp Cell Res; 2005 Oct; 310(1):152-65. PubMed ID: 16112108
[TBL] [Abstract][Full Text] [Related]
12. Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example.
Yang CW; Su JY; Tsou AP; Chau GY; Liu HL; Chen CH; Chien CY; Chou CK
Biochem Biophys Res Commun; 2005 May; 330(2):489-97. PubMed ID: 15796909
[TBL] [Abstract][Full Text] [Related]
13. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Gadd45 alleviates the G2/M blockage and the enhanced phosphorylation of p53 and p38 in zinc supplemented normal human bronchial epithelial cells.
Shih RS; Wong SH; Schoene NW; Lei KY
Exp Biol Med (Maywood); 2008 Mar; 233(3):317-27. PubMed ID: 18296737
[TBL] [Abstract][Full Text] [Related]
16. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression.
Yamaura M; Mitsushita J; Furuta S; Kiniwa Y; Ashida A; Goto Y; Shang WH; Kubodera M; Kato M; Takata M; Saida T; Kamata T
Cancer Res; 2009 Mar; 69(6):2647-54. PubMed ID: 19276355
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling pathway is a target for the treatment of colorectal cancer.
Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
[TBL] [Abstract][Full Text] [Related]
19. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
20. Histone H1 and cdk1 kinase activities in early embryos of four mouse strains after X-irradiation.
Baatout S; Müller W; Michaux A; Buset J; Schoonjans W; Jacquet P
In Vivo; 2007; 21(4):571-82. PubMed ID: 17708348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
